Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysis

INTRODUCTION: The use of fibrinolytic therapy has been proposed in severe acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, anticoagulation has received special attention due to the frequent findings of microthrombi and fibrin deposits in the lungs and other organs. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovács, Emőke Henrietta, Dembrovszky, Fanni, Ocskay, Klementina, Szabó, László, Hegyi, Péter, Molnar, Zsolt, Tánczos, Krisztián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515457/
https://www.ncbi.nlm.nih.gov/pubmed/36167378
http://dx.doi.org/10.1136/bmjopen-2022-063855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515457/
https://www.ncbi.nlm.nih.gov/pubmed/36167378
http://dx.doi.org/10.1136/bmjopen-2022-063855

Ejemplares similares